Janusz k rybakowski (35 risultati)

HARDCOVER. Condizione: Very Good. 1st edition. 117pp, octavo, tight binding, clean pages, sharp corners, soiling to the boards, mild wear and soiling to front cover.

Condizione: New.

HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Hardback. Condizione: New.

Hardcover. Condizione: new. Hardcover. Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New. pp. 117.

Condizione: New. pp. 130 1st ed. 2016 edition NO-PA16APR2015-KAP.

Hardcover. Condizione: Brand New. 117 pages. 9.25x6.25x0.50 inches. In Stock.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.…

Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.…

Paperback. Condizione: Brand New. reprint edition. 117 pages. 9.25x6.10x0.29 inches. In Stock.

Taschenbuch. Condizione: Neu. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders | Janusz K. Rybakowski (u. a.) | Taschenbuch | ix | Englisch | 2018 | Springer | EAN 9783319800615 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Hardback. Condizione: New.

Paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: new. Questo è un articolo print on demand.

Condizione: new. Questo è un articolo print on demand.

Hardcover. Condizione: new. Hardcover. This Reprint celebrates the 75th anniversary of the introduction of lithium into modern psychiatry, marked by a seminal publication by Australian psychiatrist John Cade in the Medical Journal of Australia in 1949. After three-quarters of a century, lithium has been solidified as one of the most important drugs in modern psychiatry. Ten articles by leading specialists in lithium treatment present historical accounts of the treatment's development and its current status. The main topic is the use of lithium in bipolar disorder, where it is a drug of choice for the prevention of mood recurrences. Still, it also has a place in the treatment of mania and the augmentation of antidepressants in treatment-resistant depression. In patients with mood disorders, lithium exerts a suicide-preventive effect, the strongest among the mood stabilizers. Neuroprotective effects of lithium have also been discovered, with attempts to apply it in the prevention and treatment of dementia. This Reprint provides a range of important and up-to-date information about this amazing drug. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. 128 pp. Englisch.…

Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. 128 pp. Englisch.…

Condizione: New. Print on Demand pp. 117.

Condizione: New. Print on Demand pp. 130.

Condizione: New. PRINT ON DEMAND pp. 117.

Condizione: New. PRINT ON DEMAND pp. 130.

Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Updated comprehensive review of the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depressionModern pharmacogenomics of the most important psychotropic drugs such as antipsychotics, antidepressants and .…

Hardcover. Condizione: new. Hardcover. This Reprint celebrates the 75th anniversary of the introduction of lithium into modern psychiatry, marked by a seminal publication by Australian psychiatrist John Cade in the Medical Journal of Australia in 1949. After three-quarters of a century, lithium has been solidified as one of the most important drugs in modern psychiatry. Ten articles by leading specialists in lithium treatment present historical accounts of the treatment's development and its current status. The main topic is the use of lithium in bipolar disorder, where it is a drug of choice for the prevention of mood recurrences. Still, it also has a place in the treatment of mania and the augmentation of antidepressants in treatment-resistant depression. In patients with mood disorders, lithium exerts a suicide-preventive effect, the strongest among the mood stabilizers. Neuroprotective effects of lithium have also been discovered, with attempts to apply it in the prevention and treatment of dementia. This Reprint provides a range of important and up-to-date information about this amazing drug. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…